ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,695,084 | -5.4% | 81,338 | +8.7% | 0.00% | 0.0% |
Q2 2023 | $1,792,490 | +24.2% | 74,819 | -2.4% | 0.00% | +33.3% |
Q1 2023 | $1,442,986 | +49.2% | 76,673 | +26.2% | 0.00% | 0.0% |
Q4 2022 | $967,188 | -1.3% | 60,753 | +1.4% | 0.00% | 0.0% |
Q3 2022 | $980,000 | +51.7% | 59,909 | +30.6% | 0.00% | +50.0% |
Q2 2022 | $646,000 | +11.8% | 45,877 | +91.9% | 0.00% | +100.0% |
Q1 2022 | $578,000 | +99.3% | 23,906 | +92.3% | 0.00% | 0.0% |
Q4 2021 | $290,000 | +42.2% | 12,429 | +1.1% | 0.00% | 0.0% |
Q3 2021 | $204,000 | -20.9% | 12,290 | +16.6% | 0.00% | 0.0% |
Q2 2021 | $258,000 | -42.7% | 10,540 | +25.2% | 0.00% | -50.0% |
Q4 2020 | $450,000 | +35.1% | 8,418 | +4.1% | 0.00% | 0.0% |
Q3 2020 | $333,000 | -5.4% | 8,086 | +11.1% | 0.00% | 0.0% |
Q2 2020 | $352,000 | – | 7,278 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |